RGC32/C13orf15 Polyclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Modulates the activity of cell cycle-specific kinases. Enhances CDK1 activity. May contribute to the regulation of the cell cycle. May inhibit growth of glioma cells by promoting arrest of mitotic progression at the G2/M transition. Fibrogenic factor contributing to the pathogenesis of renal fibrosis through fibroblast activation.
Synonyms
RGC32; RGC-32; C13orf15; bA157L14.2; Regulator of cell cycle RGCC; Response gene to complement 32 protein; RGCC
Gene ID
28984
Swiss Prot
Q9H4X1
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
65-137/137
Target
RGC32/C13orf15
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human RGC32
Applications
Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
28984
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15363863 1 Vial
Lentiviral human PPP2R1A sgRNA gene knockout kit - Lentiviral human PPP2R1A sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details